Sanofi-Aventis (France) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux
Reuters -- French drugmaker Sanofi-Aventis stopped developing two medicines as part of an overhaul of its research and development portfolio, saying they would not bring significant benefits.